Dipeptidyl Peptidase-IV (DPP-IV) was found to be one of the
emerging targets in the field of antidiabetic drug development. In
recent years, Piperidone analogs have shown their application in
the field of diabetology as observed in the crystallographic
structure of DPP-IV. All the ligand molecules were designed
considering the pharmacophoric features of the GGO901
(Co-crystallised ligand of DPP-IV with the PDB entry-2OQI). It was
thought worthwhile to perform docking study by extracting the
crystallographic structure of Dipeptidyl Peptidase-IV inhibitor
with all the virtually developed molecules to ensure the better
binding energy which would be well able to explain the ligand
target interaction of novel piperidone analogs, actively inhibiting
DPP-IV enzyme. Based on the docking output, a few novel imidazole
linked piperidone analogs were synthesized & as a part of the
structure elucidation process various spectroscopic data were
collected and subsequently analysed. All the analytically proven
synthesized compounds were further sent for biological evaluation.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!